Hospital discharges for adnexa and eye diseases in Mexico stand at 22.37 thousand in 2024, forecasted to decrease steadily over the next several years. By 2025, the number drops by 3.98%, reaching 21.48 thousand. A further decline of 4.10% brings the figure to 20.6 thousand in 2026, followed by a 4.29% decrease to 19.72 thousand in 2027, and down by 4.40% to 18.85 thousand in 2028. Looking at the compound annual growth rate (CAGR) between 2024 and 2028, there is an average annual decline of approximately 4.19%.
Future trends to watch for include potential shifts in public health policies, advancements in medical technology and treatment options, and changes in population health dynamics that could impact the volume of hospital discharges for adnexa and eye diseases. Monitoring these trends can provide insights into whether the observed decline will continue or if new factors may alter the trajectory.
